Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis.
Sarah KriegChristoph RoderburgStephen FungTom LueddeWolfram Trudo KnoefelAndreas KriegPublished in: Journal of cancer research and clinical oncology (2022)
Nuclear Survivin is highly expressed in more aggressive G3 GEP-NEN and correlates with a poor outcome. Survivin is therefore an interesting molecule for a targeted therapy, especially for patients with highly proliferative G3 GEP-NENs.
Keyphrases